Review paper
Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
Abstract
Statins have been shown to be effective in reducing cardiovascular events. Their magnitude of benefits has been proportionate to the reduction in low-density lipoprotein cholesterol (LDL-c). Intensive lipid-lowering therapies using ezetimibe and more recently proprotein convertase subtilisin kexin 9 inhibitors have further improved clinical outcomes. Unselective application of these treatments is undesirable and unaffordable and, therefore, has...
Paper Details
Title
Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
Published Date
Sep 26, 2021
Journal
Volume
13
Issue
9
Pages
472 - 482
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History